Shire investors to be wooed by Takeda CEO - report
16 APR 2018
Takeda Pharmaceutical [TYO:4502] Chief Executive Christophe Weber will this week visit the USA on a charm offensive aimed at shareholders in Shire [LON:SHP], The Daily Telegraphreported. The Takeda CEO is scheduling meetings with Shire’s biggest investors prior to launching a possible formal takeover bid, the report said.
JPMorgan [NYSE:JPM], Capital Group and Blackrock [NYSE:BLK] are among the largest shareholders in Shire, which is headquartered in Ireland but has an operational base in the USA.
Takeda is believed to be weighing a sale of Shire’s neuroscience arm to fund its acquisition of the business, City sources cited in the report said.
The original article appeared in The Daily Telegraph, Business section, page 5